RA
VKTX icon

Royce & Associates’s Viking Therapeutics VKTX Stock Holding History

Royce & Associates’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-75,261
Closed -$3.03M – 867
2024
Q4 		$3.03M Buy
75,261
+61,927
+464% +$3.53M 0.03% 565
2024
Q3 		$844K Buy
+13,334
New +$782K 0.01% 746
2024
Q2 		– Sell
-6,951
Closed -$570K – 916
2024
Q1 		$570K Sell
6,951
-21,086
-75% -$938K 0.01% 780
2023
Q4 		$522K Buy
+28,037
New +$367K ﹤0.01% 790
2019
Q1 		– Sell
-135,000
Closed -$1.03M – 1190
2018
Q4 		$1.03M Buy
+135,000
New +$1.61M 0.01% 853

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return